Bullish Case: Known: ASTS at $66.31; ASTS IV term structure is flat (~100%+) into late 2026, implying event risk already priced. Vodafone’s emergency D2D trial suggests utility beyond hype. If August BlueBird 11/12/13 achieve expected orbit + throughput, the vol surface’s broad demand and the historical return surface’s “most-likely” modest gains support +5% to +15% upside, with IV-cooling lagged versus earlier hopes.

Bearish Case: Known: top options show heavier put activity; ASTS vol surface stays elevated and higher on lower strikes, while SPY surface is much calmer (~10–18%). Inferred: market discounts execution/financing. The slide from ~$85 to $66 matches prior execution/dilution bearish calls; without confirmed launch success, -8% to -20% drawdowns remain plausible.

Potential Outcomes:

1. 32%: BlueBird 11/12/13 orbit + telemetry matches target → ASTS IV ~flat → +8% to +15%.
2. 25%: Orbit success but throughput short; oracle: if put IV/price don’t firm in 48h → -2% to +6%.
3. 20%: Launch slip/off-nominal; downside strikes bid persist → -12% to -25%.
4. 13%: Dilution/convert priced (secondary < VWAP); term-IV up → -8% to -18%.
5. 10%: Macro risk-off lifts SPY IV; ASTS lags → -5% to -12%.

July 16, 2026